期刊: BONE MARROW TRANSPLANTATION, 2022; 57 (4)
The efficacy and outcome of therapeutic plasma exchange (TPE) for transplant-associated thrombotic microangiopathy (TA-TMA) remain controversial. We t......
期刊: BONE MARROW TRANSPLANTATION, 2022; 57 (11)
The optimal chemotherapy regimen pre-transplantation for adult T-cell acute lymphoblastic leukemia (T-ALL) patients remains unknown. Here, we compared......
期刊: BONE MARROW TRANSPLANTATION, 2022; 57 (7)
Although haploidentical stem cell transplantation (haplo-HSCT) offers almost all acute lymphoblastic leukaemia (ALL) patients an opportunity for immed......
期刊: BONE MARROW TRANSPLANTATION, 2022; 57 (10)
The most widely used regimens of graft-versus-host disease (GVHD) prophylaxis in HLA-matched unrelated donor peripheral blood stem cell transplantatio......
期刊: BONE MARROW TRANSPLANTATION, 2022; 57 (7)
Our main purpose was to evaluate health-related quality of life (HRQOL) in beta-thalassemia major patients who underwent transplantation from Septembe......